FdaApplication
ANDA 216617
Identifiers
- fda_app_no: ANDA216617
Properties
| Property | Value |
|---|---|
| applicant_name | ASPIRO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2022-07-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ACETAMINOPHEN | ACETAMINOPHEN | 1GM/100ML (10MG/ML) | SOLUTION;INTRAVENOUS |
1 product